Never Too Late: If you missed the IPKat last week!

Busy with work? Take a moment to stay up-to-date with the latest developments in the IP world!

Trade Marks
Oliver Fairhurst explained a recent decision (O/0369/25) of the Opposition Division of the UK Intellectual Property Office applying SkyKick and upholding an opposition on bad faith grounds.Marcel Pemsel reviewed a recent decision (T-206/24) of the General Court concerning the rejection of the trade mark HOODLESS HOODIES.

Söğüt Atilla reported on a recent decision of the EUIPO Second Board of Appeal concerning distinctiveness.

A Katfriend discussed a recent ruling of the Polish court (the Warsaw Regional Court) regarding due cause.

Copyright

Eleonora Rosati analyzed the recent Opinon of Advocate General Szpunar regarding copyright protection of works of applied arts. The AG also referred two IPKat blog posts in the opening paragraph.

Patents

Rose Hughes outlined T 1701/22 concerning pharmaceutical IP, more specifically pharmaceutical composition of semaglutide for use in treatment of obesity, at a specific dose and formulation pH.

Katfriend Ian Jones (GJE) analyzed the recent decision in Generics, Teva & Glenmark v AstraZeneca [2025] EWHC 1012. The case concerned how inventive step and sufficiency are assessed in the UK in light of the concept of “plausibility”.

IP events and opportunities

Eleonora Rosati informed the Readers of various news and events, including the INTA Copyright Committee’s report on syncronization rights in audiovisual productions and the 2025 edition of GiKii 2025, which will be held at the Institute for Information Law, University of Amsterdam (The Netherlands) on 11-12 September 2025.

Source: https://ipkitten.blogspot.com/2025/05/never-too-late-if-you-missed-ipkat-last_14.html